PI3K-Akt-mTOR signaling correlated with MAPK14 expression positively (Fig. 8), pharmacological inhibitor of which had been preliminarily investigated and showed some effects on MPN in several studies [35–37]. The gene discussed is MTOR; the disease is myeloproliferative disorder.